healthcare
healthcare Articles
Melinta Therapeutics shares dropped on Monday despite the company announcing positive top-line results from its Phase 3 trial of Baxdela (delafloxacin) for the treatment of adult patients with...
Published:
Last Updated:
Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
Dicerna Pharmaceuticals and Eli Lilly are partnering up in a global licensing and research collaboration focused on the discovery, development and commercialization of potential new medicines in the...
Published:
Last Updated:
Gilead shares retreated on Friday after it reported mixed third-quarter financial results late on Thursday.
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The October 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
Alexion Pharmaceuticals reported better-than-expected quarterly results before the markets opened on Wednesday.
Published:
Last Updated:
Biopharmaceutical company Orchard RX is offering more than 13 million shares in an initial public offering valued up to more than $245 million.
Published:
Last Updated:
Pfizer, in collaboration with Bain Capital, announced the creation of Cerevel Therapeutics, a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central...
Published:
Last Updated:
Proteostasis Therapeutics shares pulled back on Tuesday after the company announced that it would be conducting a secondary offering.
Published:
Last Updated:
Mirati shares dropped on Monday after the company announced updated positive clinical data from its midstage study in non-small cell lung cancer.
Published:
Last Updated:
Medical technology company Axonics Modulation Technologies is offering more than 6 million shares in an initial public offering valued up to more than $122 million.
Published:
Last Updated:
Here is a preview of some of the world’s largest players in the health care sector reporting earnings this coming week.
Published:
Last Updated:
Clovis Oncology shares dropped on Friday after the company announced initial data from its Phase 2 clinical trial of Rubraca at the ESMO 2018 Congress.
Published:
Last Updated:
Merrimack Pharmaceuticals shares dropped early on Friday after the company announced that it would be terminating its midstage SHERLOC study in patients with non-small cell lung cancer.
Published:
Last Updated: